AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimefest M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimefest M 2mg/500mg Tablet

Diabetic patients using Glimefest M 2mg/500mg tablets, a dual-action antidiabetic medication, should be aware of its combined mechanism for managing type 2 diabetes in adults. This medication regulates blood glucose effectively when taken consistently with meals, at the same time daily. Dosage adjustments are determined by your physician based on individual blood sugar responses. Continuous use, even with controlled blood sugar, is crucial; abrupt cessation can lead to hyperglycemia and complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a holistic diabetes management plan, which must include diet modification, physical activity, and weight management as prescribed by your healthcare professional. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like tremors, sweating, dizziness, and cephalgia. Prompt treatment with fast-acting glucose sources (e.g., sugary snacks or juice) is essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential adverse effects include gastrointestinal disturbances (nausea, diarrhea, abdominal pain), altered taste perception, headaches, upper respiratory infections, and weight gain. Glimefest M 2mg/500mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, and significant hepatic or renal impairment. Patients with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring, along with periodic blood tests (complete blood count and liver function tests), are necessary for optimal treatment and safety.

Uses of Glimefest M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimefest M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimefest M 2mg/500mg Tablet with a meal.

Common Side effects of Glimefest M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimefest M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimefest M 2mg/500mg tablets should be administered with a meal.

How Glimefest M 2mg/500mg Tablet works:

Glimefest M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimefest M 2mg/500mg tablets is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimefest M 2mg/500mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing this medication. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimefest M 2mg/500mg tablets. Evidence indicates potential harm to the infant from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the 2mg/500mg Glimefest M tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Kidney function should be regularly monitored during treatment; physician consultation is essential.

LiverLiverCAUTION

Individuals with liver impairment should use Glimefest M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Glimefest M 2mg/500mg Tablet :

Should you forget to take your Glimefest M 2mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimefest M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimefest M 2mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glimefest M 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimefest M 2mg/500mg Tablet use and seek immediate medical attention.
Glimefest M 2mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a healthy lifestyle including diet and exercise. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glimefest M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Glimefest M 2mg/500mg tablets may induce Vitamin B12 deficiency with prolonged use due to impaired Vitamin B12 absorption in the gastrointestinal tract. This deficiency, if left unaddressed, can lead to anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Prophylactic Vitamin B12 supplementation, at least annually, is recommended by some experts to mitigate these risks.
Glimefest M 2mg/500mg Tablets can induce hypoglycemia (low blood sugar). This can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glimefest M 2mg/500mg tablets is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimefest M 2mg/500mg Tab...
75
MRP 91
17% off